CMB 0.00% 0.4¢ cambium bio limited

Ann: Australian Biomarker Patent Allowed, page-3

  1. 18 Posts.
    lightbulb Created with Sketch. 4
    Has Regeneus moved into positive cashflow? $676 thousand R and D payment. $1.3 million in August from Kyocera as well as a further 4 million due in October with more to come. Impressive financial momentum being generated here.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.